FDA Adverse Event Injury Summary report: N

TIGR MATRIX SURGICAL MESH

MDR report key: 5253879 · Received November 30, 2015

Report

Report Number
3010187263-2015-00005
Event Type
Injury
Date Received
November 30, 2015
Date of Event
November 6, 2015
Report Date
November 24, 2015
Manufacturer
NOVUS SCIENTIFC AB
Product Code
FTL
UDI-DI
07332999000024
PMA / PMN Number
K092224
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
DA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

NOVUS SCIENTIFIC HAS NEVER EVER RECEIVED ANY COMPLAINT REGARDING AN AUTOIMMUNE DISEASE. POLYMERS USED IN THE PRODUCT ARE WELL KNOWN AND HAVE BEEN USED IN DIFFERENT IMPLANTABLE MEDICAL DEVICES FOR DECADES. A NUMBER OF LITERATURE SEARCHES WERE PERFORMED IN PUBMED TO STUDY IF THERE EXISTS ANY LITERATURE THAT INDICATES THAT THE POLYMERS USED IN THE PRODUCT CAN CAUSE AN AUTOIMMUNE DISEASE. TOTALLY 59 ARTICLES WERE REVIEWED AND NO ARTICLE SUGGESTED THAT THE POLYMERS COULD CAUSE AN AUTOIMMUNE DISEASE. DEVICE IMPLANTED IN PATIENT.

Description of Event or Problem · 1

DURING THE AUTUMN OF 2014, THE PATIENT REPORTED INCREASING IN FATIGUE, MUSCLE PAIN, LOCALIZED STIFFNESS AND THICKENING OF THE SKIN ON THE BODY AND PROXIMAL TO THE EXTREMITIES. FURTHERMORE, THE PATIENT REPORTED TINGLING SENSATIONS IN THE LEFT UPPER LIMB AND THE LEFT SIDE OF THE FACE. FINALLY, SHE HAD DYSPNEA AND LIGHT CHEST TIGHTNESS. DERMATOLOGISTS / RHEUMATOLOGISTS HAVE DIAGNOSED STEPWISE AND NOT GENERALIZED SCLERODERMA (MORPHEA). SINCE A PET-CT SCAN HAS SHOWN A REACTION IN THE ABDOMINAL WALL IN RELATION TO THE IMPLANTED MESH, ONE HAS SUSPECTED AN IMMUNOLOGICAL REACTION TO MESH MATERIAL. THE PATIENT HAS BEEN TREATED WITH IMMUNOSUPPRESSIVE THERAPY AND UVA LIGHT THERAPY WITH REASONABLE EFFECT ON THE SYMPTOMS. THE PATIENT HAS ALSO BEEN DIAGNOSED A SLIGHT BRONCHIAL ASTHMA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
786129 TIGR MATRIX SURGICAL MESH POLYMERIC SURGICAL MESH, BIODEGRADABLE FTL NOVUS SCIENTIFC AB NSTM2030 302010413 07332999000024

Patients

Seq Age Sex Outcome Treatment
1 50 YR Required Intervention